How about shifting the reliance on medicare funding for GME (residency/fellowship) to private inititiaves such as hospital funded...

eGenesis, a biotech company based out of Cambridge, MA along with a group of surgeon/physician scientists at Massachusetts General...

Should Metformin remain as the first line agent for oral treatment of T2DM?  NYTimes piece sheds some light on how Metformin is being...